Search - tctmd.com

Displaying 1 - 20 of 157

Sort: Relevancy | Date

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

December 18, 2018

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

News Conference News WCC 2018

Is It Time to Loosen Restrictions on Saturated Fats and Salt?

December 14, 2018

Man’s Best Friend, Especially After an MI or Stroke

News Conference News WCC 2018

Man’s Best Friend, Especially After an MI or Stroke

December 11, 2018

True Resistant Hypertension Is Prevalent Worldwide

News Conference News WCC 2018

True Resistant Hypertension Is Prevalent Worldwide

December 07, 2018

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

News Conference News WCC 2018

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

December 05, 2018

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

News Daily News

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

December 03, 2018

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

News Daily News

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

November 29, 2018

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

News Daily News

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Michael O'Riordan

November 23, 2018

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

November 21, 2018

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

News Conference News AHA 2018

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

Yael L. Maxwell

November 16, 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

November 15, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

November 13, 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

News Conference News AHA 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

November 11, 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

November 10, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.